Dr. Kanhaiya Singh is an Associate Professor at the McGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh. He received his doctoral degree in Biotechnology from Banaras Hindu University, India, in 2015 and completed his post-doctoral research at The Ohio State University in 2015–2018. Before joining the University of Pittsburgh in 2023, he served as a Postdoctoral Researcher in 2018–2020 and then as an Assistant Professor in the Department of Surgery at Indiana University in 2020–2023. Dr. Singh’s
laboratory focuses on epigenetics of diabetic vasculopathy and wound healing. His laboratory is investigating epigenetic mechanisms such as DNA methylation as a proxy for abnormal gene-environmental interactions in diabetic ischemic wounds. His laboratory also investigates the molecular mechanism in diabetic vasculopathy and limb ischemia. Dr. Singh serves as an editorial board member for Nature’s Scientific Reports, an academic editor for PLoS ONE, an editor for Genetics Research, a guest editor for Oxidative Medicine and Cellular Longevity
and Frontiers in Endocrinology, and an editorial board member for NewBioWorld.
